Find and Pitch Jounalists, Get Your Story Covered

Tags: A brush with...podcast Linder Punk The Hayward Gallery Hieronymus Bosch

	Profile	Recent Articles on Subject
1	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: A reporter’s JPM notebook: a look ahead for biopharma VC investing - about 2 months ago A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids - 6 months ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 6 months ago STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - 7 months ago
2	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Key Insights From ASH and SABCS Showcase Advancements for the Field of Oncology Pharmacy - about 2 months ago Transforming Cancer Care: Innovations in Immunotherapy and the Critical Role of the Pharmacist - 7 months ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Merck is broadening its pipeline as Keytruda’s patent cliff looms - about 2 months ago What’s old is new: The revival of a one-time radiotherapy cancer treatment - 11 months ago Black Diamond looks to outwit cancer mutations - about 1 year ago
4	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	A new-year round-up of the science stories you may have missed - about 2 months ago
5	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Advances in Cancer Therapies and Diagnostics - about 2 months ago Tapping Into Immunotherapy’s Potential to Help More People - 12 months ago
6	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	STAT stories you might have missed in 2024 - 2 months ago
7	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma - 3 months ago Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in - 4 months ago 23andMe inches closes to cancer immunotherapy, guided by its genetic database - 7 months ago A ‘widening gap’ in access to new cancer meds drives efforts from City of Hope and Bristol Myers - 9 months ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago How Big Pharma keeps the oncology engines hot with a host of strategies - over 1 year ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer - 5 months ago Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 6 months ago
9	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 6 months ago The news from ESMO: The latest on anti-TIGIT data, a PD-(L)1 injection, and more - 6 months ago STAT+: Study on Amgen’s ‘bispecific’ immunotherapy could lead to approval in small cell lung cancer - over 1 year ago
10	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - 6 months ago

Journalists covering Brush-up Summaries, cancer research, drug development, immunology